-
France readies high school phone ban for next month
-
Empire State Building climbers kiss outside court after viral proposal
-
Trump says to double tariffs on Canada autos as trade fight heats up
-
French poll shows Le Pen's biggest challenger may be hard left's Melenchon
-
Noosha Aubel: Hur mycket administrativt misslyckande tål Potsdam till?
-
Noosha Aubel: Πόση διοικητική αποτυχία μπορεί να αντέξει ακόμα το Πότσδαμ?
-
WeGolden Receives Best Gold Trading Platform Asia 2026 Recognition from TrustFinance Awards
-
WeMasterTrade Receives Best Instant Prop APAC 2026 Recognition from TrustFinance Awards
-
BtcDana Wins “Best Customer Support Experience – CFD Broker 2026” at the TrustFinance Performance Awards
-
MH Markets Recognized as Most Transparent Broker at the TrustFinance Awards 2026
-
Belgian pie-thrower, scourge of celebrities, dies at 80
-
Stocks, oil slip ahead of US threat of economic war against Iran
-
Eto'o urges support for embattled FIFA president Infantino
-
Trump claims Iran 'collapsing' as US threatens 'economic D-Day'
-
India in driver's seat in second Sri Lanka Test
-
Noosha Aubel: Kolik administrativních selhání ještě Potsdam snese?
-
Noosha Aubel: Ile jeszcze nieudolności administracyjnej wytrzyma Poczdam?
-
नूशा ऑबेल: पॉट्सडैम और कितनी प्रशासनिक विफलता सहन कर सकता है?
-
ヌーシャ・オーベル:ポツダムは、あとどれだけの行政の失態に耐えられるのか?
-
누샤 아우벨: 포츠담은 행정 실패를 얼마나 더 견뎌낼 수 있을까?
-
努莎·奧貝爾:波茨坦還能承受多少行政失職?
-
نوشا أوبيل: إلى أي مدى ستتحمل بوتسدام المزيد من الفشل الإداري؟
-
Нуша Аубель: Скільки ще Потсдам витримає адміністративних провалів?
-
Нуша Аубель: Сколько ещё Потсдам сможет выдержать административных провалов?
-
Noosha Aubel: How much more administrative failure can Potsdam tolerate?
-
Despair and anger in Conakry after deadly landfill collapse
-
Liverpool must improve on 'unacceptable' season, says Van Dijk
-
OSCE says Kazakh elections lacked choice after ruling party wins landslide
-
UK PM dismisses Russian threats as Ukraine allies gather in Kyiv
-
India declare on 503-9 after Jurel hundred
-
Attacks on Red Cross in DR Congo making Ebola fight 'harder'
-
Kremlin says UK preventing peace by giving missile info to Ukraine
-
Oil falls ahead of US plan for economic war on Iran
-
Springboks change half-backs for second All Blacks Test
-
Millions of Teslas recalled in China over door handle safety
-
Jurel hits 95 not out as India reach 475-8 at tea in Sri Lanka Test
-
IUX Launches New Education Webinar Series to Support Traders’ Financial Literacy
-
Ingebrigtsen buoyed by fourth in Diamond League comeback
-
Dutch say won't participate in 'no longer' neutral Eurovision
-
Kenyans get creative to join manga cosplay craze
-
Kenyan farmers turn to bugs as organic demand grows
-
Pant, Jurel half-centuries take India past 400 in Sri Lanka Test
-
'His feet are his pillars': Nepal para swimmer gives all for Asian glory
-
Migrants, rescue ships face threats, harassment at sea: aid group
-
New Zealand moves to ban social media for under-16s
-
UEFA's Ceferin tells Infantino to go, but 'not interested' in replacing him
-
Hyundai union back in wage talks after rare full-day strike
-
Oil falls as Trump pledges economic war on Iran
-
Shein grapples with EU backlash, but clients keep coming
-
Yamashita marches to nine-shot win in LPGA Canadian Women's Open
AMC Health Appoints Sol Babani and Symbiosis Advisors as Strategic Advisor to Its Decentralized Clinical Trial Service Line
Industry veteran brings deep CRO and biopharma expertise from ICON, PRA Health Sciences, and Covance to accelerate growth and operationalization of AMC Health's DCT platform
NEW YORK CITY, NY / ACCESS Newswire / May 5, 2026 / AMC Health today announced the appointment of Sol Babani, Founder and CEO of Symbiosis Advisors, as Strategic Advisor to its newly established Decentralized Clinical Trial (DCT) service line. Babani will work closely with CEO Nesim Bildirici and Keith Tode, Executive Vice President of Decentralized Clinical Trials, to grow and operationalize AMC Health's DCT platform as it expands its modular operating partner offering to biopharmaceutical sponsors, medical device companies, and CROs.
"As we move into active commercialization of our DCT service line, Sol's depth across the CRO and sponsor landscape is exactly the strategic muscle we need. He's not just advising, he's helping us build the commercial engine."
- Nesim Bildirici, Chief Executive Officer, AMC Health
ABOUT SOL BABANI & SYMBIOSIS ADVISORS
Sol Babani is the Founder of Symbiosis Advisors, a strategic advisory firm serving start-up and mid-market healthcare and life sciences companies. Symbiosis specializes in positioning organizations for growth, preparing them for the scrutiny of transactions, and building strategic partnerships and alliances - embedding directly within client leadership teams to align expertise with vision.
Babani brings decades of senior CRO and biopharma industry experience, having served as Senior Vice President at ICON Biotech, Senior Vice President of Drug Development at PRA Health Sciences, and Vice President of Biopharma Solutions at Covance. His career spans pharma, biotech, and medical device, giving AMC Health access to one of the most experienced commercial and operational minds in the clinical research industry.
"What caught my attention about AMC Health is how few companies in this space have both the clinical infrastructure and the operational maturity to serve as a true operating partner. That combination is rare, and it's exactly what the sponsor and CRO market is looking for right now."
- Sol Babani, Founder, Symbiosis Advisors & Strategic Advisor, AMC Health DCT
A STRATEGIC PARTNERSHIP BUILT FOR GROWTH
The appointment of Babani and Symbiosis Advisors reflects AMC Health's commitment to building its DCT service line with the commercial rigor and strategic infrastructure required to compete at the highest level of the clinical research market. With Babani's network and expertise in CRO and sponsor partnerships, AMC Health is positioned to accelerate the adoption of its modular DCT operating model across the life sciences industry.
ABOUT AMC HEALTH
AMC Health is a remote patient monitoring and decentralized clinical trial services company with a proven track record supporting the U.S. Department of Veterans Affairs. Through its DCT Platform, AMC Health delivers modular operating partner services to biopharmaceutical sponsors, medical device companies, and CROs across fully remote and hybrid clinical study designs. For more information, visit www.amchealth.com.
ABOUT SYMBIOSIS ADVISORS
Symbiosis Advisors is a strategic advisory firm helping start-up and mid-market healthcare and life sciences companies position themselves for success, prepare for transactions, and build top-tier strategic partnerships and alliances. Symbiosis works side by side with client leadership teams, embedding expertise directly within the organization to build stronger, more valuable companies. For more information, visit www.symbiosisadvisors.com.
Contact Information
Gary Feiner
Director of Marketing
[email protected]
(877) 262-2240
SOURCE: AMC Health
View the original press release on ACCESS Newswire
A.Ruiz--AT